ATE42202T1 - Therapeutische zubereitung mit ammoniumnitrat als wirkstoff. - Google Patents
Therapeutische zubereitung mit ammoniumnitrat als wirkstoff.Info
- Publication number
- ATE42202T1 ATE42202T1 AT85200870T AT85200870T ATE42202T1 AT E42202 T1 ATE42202 T1 AT E42202T1 AT 85200870 T AT85200870 T AT 85200870T AT 85200870 T AT85200870 T AT 85200870T AT E42202 T1 ATE42202 T1 AT E42202T1
- Authority
- AT
- Austria
- Prior art keywords
- ammonium nitrate
- active substance
- therapeutic preparation
- therapeutic
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8401782A NL8401782A (nl) | 1984-06-04 | 1984-06-04 | Therapeutisch preparaat met ammoniumnitraat als werkzame stof. |
EP85200870A EP0167191B1 (de) | 1984-06-04 | 1985-06-03 | Therapeutische Zubereitung mit Ammoniumnitrat als Wirkstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE42202T1 true ATE42202T1 (de) | 1989-05-15 |
Family
ID=19844041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85200870T ATE42202T1 (de) | 1984-06-04 | 1985-06-03 | Therapeutische zubereitung mit ammoniumnitrat als wirkstoff. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4777044A (de) |
EP (1) | EP0167191B1 (de) |
JP (1) | JPS6261921A (de) |
AT (1) | ATE42202T1 (de) |
BE (1) | BE901924A (de) |
DE (1) | DE3569471D1 (de) |
NL (1) | NL8401782A (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880291A (en) * | 1988-02-04 | 1989-11-14 | American Telephone & Telegraph Company, At&T Bell Laboratories | Optical fiber connector and methods of making |
US4919509A (en) * | 1989-02-03 | 1990-04-24 | At&T Bell Laboratories | Mechanical connection for polarization-maintaining optical fiber and methods of making |
US5016971A (en) * | 1989-10-20 | 1991-05-21 | Hughes Aircraft Company | Automated laser fusion system for high strength optical fiber splicing |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
DE69227240T2 (de) * | 1991-01-16 | 1999-04-08 | Fmc Corp | Träger für wirkstoffe und damit hergestellte feste darreichungsformen |
US6106865A (en) * | 1995-01-09 | 2000-08-22 | Edward Mendell Co., Inc. | Pharmaceutical excipient having improved compressibility |
US6936277B2 (en) | 1995-01-09 | 2005-08-30 | J. Rettenmaier & Soehne Gmbh & Co. Kg | Pharmaceutical excipient having improved compressibility |
US6395303B1 (en) * | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
SE9700617D0 (sv) * | 1997-02-21 | 1997-02-21 | Kjell Alving | New composition |
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
DK1875918T3 (da) * | 2006-07-03 | 2014-01-13 | Rainbow Pharmaceutical Sa | Ny anvendelse af ammoniumchlorid til terapi af fuldstændig eller partiel hepatisk svigten og nekrose |
US8840934B2 (en) | 2009-01-02 | 2014-09-23 | Rainbow Pharmaceutical Sa | Uses of ammonium chloride |
DE102013110608A1 (de) * | 2013-09-26 | 2015-03-26 | Florian Lang | Substanz zur Hemmung von Gewebskalzifizierung, Gewebsfibrosierung und altersassoziierten Erkrankungen |
CN105596361A (zh) * | 2015-09-30 | 2016-05-25 | 王松灵 | 硝酸盐防治骨质疏松的新用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2201086A1 (en) * | 1972-10-03 | 1974-04-26 | Madier Julien | Ammonium nitrate medicament - for treating acne, baldness, sunstroke, wrinkles and mycosis |
US4466960A (en) * | 1983-10-18 | 1984-08-21 | Thompson Medical Co., Inc. | Analgesic-diuretic compositions |
-
1984
- 1984-06-04 NL NL8401782A patent/NL8401782A/nl not_active Application Discontinuation
-
1985
- 1985-03-13 BE BE0/214637A patent/BE901924A/nl not_active IP Right Cessation
- 1985-06-03 DE DE8585200870T patent/DE3569471D1/de not_active Expired
- 1985-06-03 EP EP85200870A patent/EP0167191B1/de not_active Expired
- 1985-06-03 AT AT85200870T patent/ATE42202T1/de not_active IP Right Cessation
- 1985-09-11 JP JP60201466A patent/JPS6261921A/ja active Pending
-
1987
- 1987-09-09 US US07/096,303 patent/US4777044A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BE901924A (nl) | 1985-09-13 |
DE3569471D1 (en) | 1989-05-24 |
JPS6261921A (ja) | 1987-03-18 |
EP0167191A1 (de) | 1986-01-08 |
NL8401782A (nl) | 1986-01-02 |
US4777044A (en) | 1988-10-11 |
EP0167191B1 (de) | 1989-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE42202T1 (de) | Therapeutische zubereitung mit ammoniumnitrat als wirkstoff. | |
ATE46080T1 (de) | Pharmazeutische komposition. | |
NL980013I1 (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
MY101544A (en) | Pharmaceutical composition for external use containing active-type vitamin d3. | |
NL190664C (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
DE3587577T2 (de) | Antimykotische pharmazeutische Präparate. | |
AU2068876A (en) | Entrapped biologically active materials | |
IL74666A0 (en) | Storage-stable,quick-disintegrating pressed shapes containing pharmaceutical active substances | |
AU7200387A (en) | Device for self-administration of physiologically active substances, with prevention of overdosing | |
ES2011120A6 (es) | Forma de dosificacion para tratar las enfermedades cardiovasculares. | |
NL194239B (nl) | Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten. | |
AU513890B2 (en) | Water-insoluble biologically active compounds | |
MY8500945A (en) | New cyclopropanecarboxycates, their production and insecticide containing them as an active ingredient | |
ES8105145A1 (es) | Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal | |
DK0605483T3 (da) | Drivmiddel for aerosoler og doseringsaerosoler | |
IL56648A0 (en) | Stabilized azulmic acides,their preparation and their uses | |
DE3575073D1 (de) | Persimonensaft als wirkstoff enthaltendes deodorant. | |
DE3378909D1 (en) | Physiologically active substance p-23924, its production and use | |
AU509127B2 (en) | W-nor-aromatic-13, 14-dehydro-prostaglandins and pharmaceuticals | |
ES8105148A1 (es) | Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas | |
IE782158L (en) | Fungicidal butyrolactones and butyrothiolactones | |
AU572643B2 (en) | Insecticidal composition of an o-alkyl-n- phenylthiocarbamate and n,n-diethyl-m-toluamide | |
ATE84221T1 (de) | Arzneimittel mit methylcellulose. | |
IT8468196A1 (it) | Dispositivo osmotico e procedimento per l'erogazione di un agente benefico, particolarmente di un farmaco ad un ambiente d'uso. | |
AU513963B2 (en) | Biologically active substance having insulin secretion promoting activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |